share_log

中信建投证券股份有限公司关于南京医药股份有限公司非公开发行股票之2023年持续督导现场检查报告

CITIC Construction Investment Securities Co., Ltd.'s 2023 Continued Supervision Site Inspection Report on the Non-public Offering of Shares by Nanjing Pharmaceutical Co., Ltd.

SZSI ·  Mar 19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more